Dermira, Inc.

Industry · 10 registered clinical trials.

Status	Trial	Phase	Started
Completed	A Long-term Safety Study of Olumacostat Glasaretil Gel in Subjects With Acne Vulgaris Acne Vulgaris	Phase 3	2017-03-21
Completed	A Study of Olumacostat Glasaretil Gel in Subjects With Acne Vulgaris Acne Vulgaris	Phase 3	2017-02-06
Completed	A Study of Olumacostat Glasaretil Gel in Subjects With Acne Vulgaris Acne Vulgaris	Phase 3	2016-12-27
Completed	A Dose-ranging Study of DRM01 in Subjects With Acne Vulgaris Acne Vulgaris	Phase 2	2015-04-01
Completed	A Safety and Efficacy Study of DRM02 in Subjects With Plaque Psoriasis Psoriasis	Phase 2	2013-10-01
Completed	A Safety and Efficacy Study of DRM02 in Subjects With Rosacea Rosacea	Phase 2	2013-10-01
Completed	A Safety and Efficacy of DRM02 in Subjects With Atopic Dermatitis Atopic Dermatitis	Phase 2	2013-10-01
Completed	A Safety, Tolerability and Preliminary Efficacy Study of DRM01B Topical Gel Acne Vulgaris	Phase 1 / Phase 2	2013-08-01
Completed	Open-label Safety and Tolerability Study of LTS-PDT in Healthy Volunteers Acne Vulgaris	Phase 1	2013-04-01
Completed	Phase 1/2 Sequentially Staged Safety Study in Healthy Subjects and Subjects With Mild Acne Acne	Phase 1 / Phase 2	2011-12-01